We are researching if a monthly GLP-1 RA study medicine can help improve symptoms of stress urinary incontinence (SUI) in women living with overweight or obesity. 

Women living with overweight or obesity are more likely to experience bladder leaks from movements like coughing, sneezing, and exercising—a condition known as stress urinary incontinence (SUI). Losing just 5% to 10% of body weight has been shown to help decrease incontinence episodes and is often the first treatment doctors recommend.1 

If you decide to join the Vesper-SUI study, your overall health and SUI symptoms will be closely monitored. You will also receive guidance on diet, exercise, and lifestyle from a team of weight loss specialists and be given a variety of tools to support you every step of the way.

Who may participate

Each clinical trial has its own guidelines for who can participate, called eligibility criteria. Some of the eligibility criteria to participate in this clinical trial include:

Stress urinary incontinence

Experience bladder leaks multiple times per week due to physical activity or movement such as sneezing, coughing, or exercise

Overweight or obesity

Body mass index (BMI) of 27 or higher 

Age

18+ years

Sex

Assigned female at birth

Additional requirements apply

The study team will discuss other requirements with you and determine if you are eligible to participate in this clinical trial. 

What to expect

Before you decide to join this clinical trial, the study team will perform some screening tests to see if the study is a good fit for you. 

If you meet all the requirements, your participation will last about 63 weeks with in-person or telehealth visits approximately every 4 weeks. 

During the Treatment Period, you will be randomly assigned (like pulling a number out of a hat) to receive either the study medicine or a placebo. The placebo looks like the study medicine but does not have any active ingredients in it. You will reach your target monthly dose through gradual dose escalation. 

Both the study medicine and the placebo will be given as an injection under the skin. You, or a caregiver, will be instructed on how to give the injections at home. 

After you finish the Treatment Period, you will have 2 additional follow-up visits.

Length of study treatment

52 weeks

Number of study visits

About 13 in-person visits and 4 telehealth visits

Study-related costs

No cost to participate, and health insurance is not required

About the study medicine

The study medicine is a GLP-1 RA (glucagon-like peptide-1 receptor agonist). It mimics the effects of a hormone in your body called GLP-1 which helps control your appetite and blood sugar. Along with a healthy diet and exercise, it may help people manage their weight by: 

  • Increasing a feeling of fullness after eating 
  • Slowing down digestion
  • Reducing appetite 
  • Regulating blood sugar levels

The study medicine is designed to be long acting, which may allow for people to achieve their weight loss goals with only 1 dose per month once they reach their target dose.

Why your participation matters

For many women, finding solutions to manage their weight and SUI symptoms can be a challenge. We are committed to advancing research that may expand weight management options for women living with SUI and overweight or obesity. 

Many factors—including age, overall health, lifestyle, and individual differences—can affect weight management and how a person responds to potential treatment. That’s why it’s important for this clinical trial to include women from a wide range of backgrounds. This will help researchers better understand the study medicine and how it may work for different people. 

Your participation and commitment could make a difference for women looking for treatment options to help manage their weight and improve their SUI symptoms.

About stress urinary incontinence (SUI)

Stress urinary incontinence (SUI) occurs when urine accidentally leaks due to increased pressure on the bladder. It’s caused by weakened muscles in the pelvic floor that affect bladder control. SUI symptoms can be triggered by any physical activity or movement that puts sudden pressure on the bladder like coughing, sneezing, and exercise. 

Women have a greater risk for developing SUI. SUI symptoms often occur during pregnancy, after childbirth, and as women get older. Carrying excess weight in the stomach area can also lead to or worsen SUI symptoms because it puts more pressure on the bladder. 

Losing weight, making healthy lifestyle changes, and doing exercises to strengthen the muscles that support the bladder may help reduce leaks and improve bladder control. Some women may also benefit from surgery for their SUI symptoms.

Frequently asked questions

What will be provided in the Vesper-SUI study?

If you qualify and decide to participate, you will receive: 

  • All study-related visits, assessments, and the study medicine at no cost 
  • Reimbursement for study-related expenses such as parking and other transportation costs
  • Guidance on diet, exercise, and lifestyle from a team of weight loss specialists, and a variety of tools to support you
Is this helpful?
Why do some participants get a placebo?

A placebo looks like the study medicine but does not have any active ingredients in it. It is used so that researchers can see if there are differences in how people respond to the study medicine.

Whether you are in the placebo group or the study medicine group, you will be making a difference to our understanding of how the study medicine works.

Is this helpful?
What are the side effects?

Because the study medicine affects digestion, some people may experience side effects like nausea, vomiting, diarrhea, and/or constipation. The study team can advise on ways to manage or minimize these types of side effects, such as eating smaller meals, drinking plenty of fluids, and eating only when hungry.

There are other common side effects that the study team will explain before you join the clinical trial.

Is this helpful?
Will I need to follow a specific diet program as part of the clinical trial?

The study team will work with you to develop a diet plan, including a reduced daily calorie intake goal, to help you lose weight in a healthy way.

 They will also provide you with regular nutritional counseling to help you meet your weight loss goals.

Is this helpful?
Will I need to exercise during the clinical trial?

You will be asked to complete at least 150 minutes of exercise per week. A wide variety of resources will be available to help you plan your physical activities and keep you motivated.

 

Is this helpful?
What if I change my mind?

Participation is completely voluntary. You can leave the clinical trial at any time and for any reason, without affecting your regular medical care or benefits.

Is this helpful?
Learn more
Discover locations for this study
Discover
Reference:
  1. Subak LL, Whitcomb E, Shen H, et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174(1):190-195. doi:10.1097/01.ju.0000162056.30326.83

Continue exploring

How clinical trials work

Steps to join a clinical trial

Protecting your safety & privacy

FAQs